Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
about
Angiogenesis and antiangiogenic agents in cervical cancer.Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women.The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates.Papillomavirus E5: the smallest oncoprotein with many functions.Anti-tumor effects of genetic vaccines against HPV major oncogenes.Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.Characterization of Cyclooxygenase-2 and its induction pathways in response to high lipid diet-induced inflammation in Larmichthys crocea.Effects of Tetrahydrocurcumin on Tumor Growth and Cellular Signaling in Cervical Cancer Xenografts in Nude MiceGW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signalingRare case of malignant transformation of recurrent respiratory papillomatosis associated with human papillomavirus type 6 infection and p53 overexpressionEmerging biological treatments for uterine cervical carcinoma.Plants and cervical cancer: an overview.Immunotherapy and targeted therapy for cervical cancer: an update.HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer.Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.Human papillomavirus E5 protein, the undercover culprit of tumorigenesis
P2860
Q34655335-0191528A-8712-4F30-911D-1B215EABF180Q34953460-981F2637-337E-41CB-B928-F0A164C05B3CQ35245080-336F5630-C1A7-4DCB-A58D-F17054B6FEE4Q35624625-693FDCFE-165A-426C-A039-655ACC6CE5F4Q35642759-22031742-F656-49BC-A352-6DF3D9D4F593Q35887186-6AE23B6B-65C6-4BBC-9AF8-59FABF29DFF9Q36482809-B2239C6D-CAD1-473C-B5E9-5F9D971973E9Q36527068-63F76FB3-0BD8-4B04-8994-D20B4D04342CQ36530104-C384CDF2-5507-4CCD-94F0-E66C0C8C3672Q36775030-A8B0DABA-D411-449D-8023-2D8794E63370Q36803963-B2DF40F6-86DF-445A-8DF4-90DF8851E079Q37540968-4E5B57F8-1C45-4F88-A829-B827FFFD983DQ38116083-4D9ADBD5-AE55-49A8-9DA6-2EFA0AD186B2Q38633525-2C6F6BE4-2FEE-447C-980D-31EB3A3ABA99Q39076137-B7E44505-0A08-4EE1-890F-7413B23E4924Q45872498-5A02F77F-DE47-4BDC-B89A-550A45812D6CQ47095819-96112282-0F85-4585-BFE5-ACBB9E013F0AQ53275556-E33F7701-5E7B-41FF-ACDD-DAFBBEF16A80Q54215275-D5EE25E7-98E7-4C74-8D61-518D688C764BQ59137003-B36152CB-D1C5-47D6-9278-8BF0EC763D8D
P2860
Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@en
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@nl
type
label
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@en
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@nl
prefLabel
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@en
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@nl
P2093
P1476
Human papillomavirus type 16 E ...... for cervical cancer treatment.
@en
P2093
Hee Seung Kim
Jae Yong Han
Jeong Mook Lim
Jung-Min Oh
Mi-Kyung Kim
Su-Hyeong Kim
Yong-Sang Song
Yong-Sung Juhnn
P304
P356
10.1016/J.BCP.2010.07.013
P407
P577
2010-07-17T00:00:00Z